Pharmaceuticals

Arcalyst (rilonacept) Market Forecast 2026–2030 Highlighting Expansion Across Industries

May 5, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Arcalyst (rilonacept) Market Expected To Scale Between 2026 And 2030?

The arcalyst (rilonacept) market has experienced significant expansion in recent times. This market is projected to expand from $0.24 million in 2025 to $0.26 million in 2026, demonstrating a compound annual growth rate (CAGR) of 7.3%. Historically, this growth can be attributed to factors such as the identification of IL-1 driven diseases, a scarcity of alternative treatments for rare inflammatory conditions, robust clinical results achieved with rilonacept, successful regulatory approvals for orphan indications, and the increasing adoption of biologic therapies by specialists.

The market for arcalyst (rilonacept) is anticipated to demonstrate significant expansion in the coming years. Its valuation is projected to reach $0.33 million by 2030, growing at a compound annual growth rate (CAGR) of 6.5%. The expansion during this forecast period can be attributed to an increase in the diagnosis of autoinflammatory syndromes, the broadening of its applications to additional indications, advancements in genetic screening, enhanced accessibility to biologic therapies, and a rise in investment toward rare disease treatments. Dominant trends expected over the forecast period include the increasing adoption of IL-1 blocking therapies, wider application in rare autoinflammatory disorders, the development of treatments for long-term inflammation control, a greater focus on targeted cytokine inhibition, and improvements in disease management for chronic inflammatory conditions.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19877&type=smp

What Key Factors Are Shaping The Arcalyst (rilonacept) Market Landscape?

The increasing need for personalized treatments is anticipated to fuel the expansion of the arcalyst (rilonacept) market moving forward. Personalized medicine refers to a medical methodology that tailors treatment and healthcare choices to the specific characteristics of each patient, such as their genetics, environment, and lifestyle. The rising demand for personalized medicine is attributed to its potential to enhance treatment effectiveness, minimize adverse effects, and address individual variations in disease progression and how drugs are metabolized. As personalized medicine becomes more widespread, there is heightened awareness and improved diagnostic tools available for identifying rare and genetically driven conditions. This consequently leads to more individuals being diagnosed with conditions that Arcalyst can treat, resulting in an increased demand for the medication. For instance, in February 2024, a report published by the Personalized Medicine Coalition (PMC), a US-based non-profit organization, indicated that the FDA approved 16 new personalized treatments for rare disease patients in 2023, a notable rise from the six approvals recorded in 2022. Additionally, according to PMC in February 2023, the FDA approved 12 new personalized medicines in 2022, marking the eighth consecutive year where personalized medicines comprised at least a quarter of all new drug approvals. Therefore, the growing demand for personalized medicines is actively driving the growth of the arcalyst (rilonacept) market.

Which Segment Types Are Examined In The Arcalyst (rilonacept) Market Segment Study?

The arcalyst (rilonacept) market covered in this report is segmented –

1) By Type: Lyophilized, Liquid

2) By Indication: Cryopyrin-Associated Periodic Syndromes (CAPS), Deficiency Of Interleukin-1 Receptor Antagonist (DIRA), Other Indications

3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By End User: Adult Patients, Pediatric Patients

What Trends Are Influencing The Arcalyst (rilonacept) Market?

Leading companies within the Arcalyst (rilonacept) market are prioritizing indication expansion, such as interleukin 1 trap therapy for recurrent pericarditis, to secure a competitive advantage. Interleukin-1 trap therapy is a treatment designed to block excess IL-1 proteins, thereby reducing harmful inflammation in the body. For example, in May 2024, Kiniksa Pharmaceuticals, a US-based biopharmaceutical company, achieved FDA approval for Arcalyst for recurrent pericarditis. This approval highlights features like weekly subcutaneous dosing, dual IL 1a/IL 1ß blockade, and a favorable safety profile for long-term use. This expansion significantly broadens Arcalyst’s addressable patient population beyond its initial Cryopyrin-Associated Periodic Syndromes (CAPS) indication. However, this wider application may subject the drug to increased competition, require ongoing long-term safety monitoring, and attract greater scrutiny from payors.

Which Players Are Part Of The Competitive Landscape Of The Arcalyst (rilonacept) Market?

Major companies operating in the arcalyst (rilonacept) market are Regeneron Pharmaceuticals Inc., Kiniksa Pharmaceuticals Ltd.

Get The Full Arcalyst (rilonacept) Market Report:

https://www.thebusinessresearchcompany.com/report/arcalyst-rilonacept-global-market-report-

Which Region Dominates The Arcalyst (rilonacept) Market By Market Share?

North America was the largest region in the arcalyst (rilonacept) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arcalyst (rilonacept) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Arcalyst (rilonacept) Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/arcalyst-rilonacept-global-market-report-

Browse Through More Reports Similar to the Global Arcalyst (rilonacept) Market 2026, By The Business Research Company

Trade Finance Market Report 2026

https://www.thebusinessresearchcompany.com/report/trade-finance-global-market-report

Petrochemicals Market 2026

https://www.thebusinessresearchcompany.com/report/petrochemicals-market

Synthetic Emerald Market Report 2026

https://www.thebusinessresearchcompany.com/report/synthetic-emerald-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795